High-profile cancer startup Juno Therapeutics is spending money on a manufacturing facility of its own, leasing a Washington plant to produce its complex cell therapies for clinical trials and keep pace with rival Novartis.

…read more

Source: Juno takes the manufacturing plunge in a high-stakes CAR-T race


0 No comments